Physician profile
Wei Han
NPI 1275989394
$729.75
in general payments reported to CMS, 2019-2025
18 companies · $176 in 2025
The $176 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $46.14 · 2020: $39.19 · 2022: $61.50 · 2023: $248 · 2024: $159 · 2025: $176.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $583.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $582.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $240.10 | 2023-2025 | |
| Exact Sciences Corporation | $65.72 | 2023-2025 | Cologuard Collection Kit |
| Tolmar, INC. | $50.46 | 2024-2025 | Jatenzo |
| Medtronic, INC. | $48.40 | 2023-2025 | Intellis Adaptivestim, Inceptiv |
| Novo Nordisk INC | $47.39 | 2022-2024 | Wegovy |
| Cumberland Pharmaceuticals, INC. | $40.47 | 2019-2020 | |
| Amgen INC. | $39.94 | 2022-2024 | Otezla, Repatha |
| Novartis Pharmaceuticals Corporation | $26.91 | 2024 | |
| Dexcom, INC. | $23.77 | 2023 | Dexcom G6 Transmitter |
| Kyowa Kirin, INC. | $20.08 | 2025 | |
| Lilly USA, LLC | $18.93 | 2022 | |
| Tactile Systems Technology INC | $18.55 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.11 | 2024 | Jardiance |
| Takeda Pharmaceuticals U.S.A., INC. | $15.42 | 2022 | |
| Astrazeneca Pharmaceuticals Lp | $15.32 | 2023 | Farxiga |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lundbeck LLC | $14.87 | 2024 | Rexulti |
| Merck Sharp & Dohme LLC | $14.40 | 2019 | |
| Pfizer INC. | $11.91 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wei Han listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.